chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Starting midnight of day of administration (10/30/13), patient, developed soreness/discomfort at injection site and neck area; discomfort spread down left arm to hand and some redness and minor swelling of little fingers.
approx 24hr p/vax pt exp several hr of inconsolable crying;went to ER no signs of infect or illness found;had been being treated for OM w/ATB (not acute);T97.2, P126, R28, weight 18#;
Information has been received from a female consumer who on 23-JUL-2010 was vaccinated with ZOSTAVAX (Merck) once injection. Pertinent medical history, drug reactions or allergies were unspecified by reporter. On approximately 13-SEP-2010 (reported as"now"), the patient experienced tingling and prickling feeling all over her body. At the time of reporting, the outcome of the patient was not provided. No further information is available.
Patient states felt dizziness and nauseous about 1 hour after getting  2nd vaccination.
Pt experienced acute & sudden abdominal pain along w/ diaphoresis & shortness of breath.Went to ER & dxed w/ acute pancreatitis & hypokalemia; subsequently hospitalized.
Pt. states her armpit to elbow was sore.  She states this was still present 6weeks later when she seeked medical attention.  She now has loss of flexibility in that arm and is unable to lift heavy thing.  States that and MRI shows inflammation of tendons.
Gave 22 yr old DTAP instead of TDAP. This medication did reach the patient, resulting in no harm to the patient. DTAP counts as valid dose. Occurred in a Health Department. TRIPEDIA by Sanofi Pasteur. 1 dose of DTAP, .5ml, intramuscular. As nurse was entering vaccine into XXXX program (XXXXXXXXXXXX Immunization Registry) via computer, noticed dose was pediatric and not for adult. Recommendation for error prevention would be to enter into XXXX computer site before adm. dose to person and if unsure of which vaccine to give, re. age, etc, to ask someone.
Headache  chills  Narrative:  Received 2nd vaccine on 3/19/2021 at 130 pm. Reaction started on  Sat with HA, arm pain at site of injection. Felt fatigued on Sun and had chills.  Employee was notified that these are normal side effects and should reside within  24-48 hours   Other Relevant History:
p/vax pt rpt dizziness; tinnitus;joint pains; seen @ clinic & Dx: flu;home;next day worse; hosp;renal failure; devel liver abscess; has had 2 operations for drainage;being weaned off ventilator;suspected lot contamination;
Heart palpitations 4days after second and third mrna vaccination; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 58-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01May2021 12:00 (Batch/Lot number: unknown) at the age of 58 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hbp" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), administration date: 01Apr2021, when the patient was 58 years old, for COVID-19 immunization. The following information was reported: PALPITATIONS (medically significant) with onset 05May2021 12:00, outcome "not recovered", described as "Heart palpitations 4days after second and third mrna vaccination". The event "heart palpitations 4days after second and third mrna vaccination" was evaluated at the emergency room visit. Therapeutic measures were taken as a result of palpitations with Beta blockers. Mag.  Additional information: Patient received third dose on 01Dec2021 at 12:00 PM administered in right arm for COVID-19 immunization. other vaccine on same date Pfizer mrna first dose on 01Dec2021 administered in left arm. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient not diagnosed with covid-19 prior to vaccination and since vaccination patient not tested for covid-19. This case assessed as non-serious by the reporter.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
difficulty breathing; soreness after 1st dose left arm; Clot in Lung; chest pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PULMONARY THROMBOSIS (Clot in Lung) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Heart disorder.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In March 2021, the patient experienced PULMONARY THROMBOSIS (Clot in Lung) (seriousness criterion medically significant) and CHEST PAIN (chest pain). On 29-Mar-2021, the patient experienced VACCINATION SITE PAIN (soreness after 1st dose left arm). On an unknown date, the patient experienced DYSPNOEA (difficulty breathing). On 30-Mar-2021, VACCINATION SITE PAIN (soreness after 1st dose left arm) had resolved. At the time of the report, PULMONARY THROMBOSIS (Clot in Lung), CHEST PAIN (chest pain) and DYSPNOEA (difficulty breathing) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, Echocardiogram: normal (normal) Normal. On an unknown date, Computerised tomogram: abnormal (abnormal) Blood clot in Lung. On an unknown date, Pulmonary function test: normal (normal) came back perfect.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 08-Mar-2021 patient had an echocardiogram (results are not provided). Concomitant medications are not reported. No Treatment for events is provided. Based on the current available information which includes a strong temporal association between the use of mRNA-1273 vaccine and onset of the reported events, causal relationship cannot be excluded. Vaccination site pain is consistent with the known safety profile of the vaccine   This case was linked to MOD-2021-084017 (Patient Link).; Sender's Comments: Based on the current available information which includes a strong temporal association between the use of mRNA-1273 vaccine and onset of the reported events, causal relationship cannot be excluded. Vaccination site pain is consistent with the known safety profile of the vaccine
Injection site was swollen and extra sensitive the next day, but patient was extremely fatigued on the 26th and 27th and just started getting better on the 28th. She also reported a fever. Sounds like a stronger than normal adverse reaction to the Pneumovax 23 (but also had the quadravalent influenza vaccine).
Developed a reddened knot approx. 5 cm in diameter at injection site. This was warm / painful to touch. Some bruising noted. Also nausea and headache present. Symptoms resolved by Monday (10/12/15). Benadryl gel was applied to the site as needed, no other treatment was required.
Developed red, blistered rash on arm below injection site. Was advised to take Zyrtec. Two follow up calls were made to pt over the following week. At time of first call she reported improvement of rash and at second follow call reported resolution.
Information has been received from a healthcare worker, for VARIVAX (Merck), a Pregnancy Registry product, concerning a 39 year old female patient with no medical and no allergies who on 22-FEB-2010 was vaccinated with a single 0.5 ml dose of VARIVAX (Merck) (lot # 665587/1203Y). There was no concomitant medication. On 22-FEB-2010 the consumer received VARIVAX (Merck) inadvertently while being pregnant. The patient's LMP was "about 5 months" in approximately September 2009, and expected date of delivery date was in approximately July 2010. The patient sought medical attention by "office called her". Follow-up information has been received from the healthcare worker concerning the 39 year old female with a history of 8 pregnancies, 3 live births, stillbirth or miscarriage occurrence (<12 weeks), no birth defect occurrence in previous pregnancy and no illness at time of vaccination who on 22-FEB-2010 at 12:00 was vaccinated SQ with a dose of VARIVAX (Merck) (lot # 665587/1203Y) in her left arm. The patient was 5 month pregnant and was given VARIVAX (Merck). The patient was seen by a doctor on 24-FEB-2010. It was unknown if the patient was tested for varicella antibodies before vaccination with VZV containing vaccine. On 09-MAR-2010, ultrasound was performed due to vaginal bleeding and the result was normal with some clot, off work for 1 week then reevaluated next week. Maternal serum-alpha-fetoprotein (MSAFP) was declined. It was unknown if the patient had local reaction at vaccination site. It was unknown if the patient had varicella (chickenpox) symptoms or herpes zoster (shingles) symptoms post vaccination. Follow-up information has been received from a registered nurse in the obstetrician/gynecologist (OB/GYN) office. The patient was an established patient (last office visit in August 2010). The patient had been "fired" from the practice due to a very large financial matter. The consumer's chart had been frozen with no access. No additional information was available. Additional information was received from a receptionist in the patient's primary care physician's office who reported the patient's last office visit was in November 2008. The patient was not given the VARIVAX (Merck) at this physician's office. The patient was now considered lost of follow-up (LTF). Additional information is not expected.
Severe nausea, chills, cold-sweats, lightheadedness. Woke up abruptly with symptoms. Took two (8mg) Zofran tablets (I have a prescription due to my colitis) which subsided the nausea allowing me to get back to slip within an hour. No other affects since them.
Swelling in lower arm and elbow. Itching in lower arm and pain in the elbow joint.
Moderna COVID-19 vaccines were given after 12 hours of the bottle being out and punctured; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccines were given after 12 hours of the bottle being out and punctured) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 084J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccines were given after 12 hours of the bottle being out and punctured). On 27-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccines were given after 12 hours of the bottle being out and punctured) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that the vial was initially stored in the refrigerator on 13 Jan 2022. The vial was first punctured on 26 Jan 2022 at 8:20 AM. Reporter stated that the vial was stored at room temperature after it was punctured.  It was reported that the patient was on unspecified concomitant medication. No treatment medications were reported.   This case was linked to MOD-2022-464853 (Patient Link).
LOSS OF VOICE, RASPY VOICE, DIFFICULTY PROJECTING VOICE; SORE THROAT; SORE ARM; This spontaneous report received from a patient concerned a 55 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-MAR-2021, the subject experienced sore arm. On 11-MAR-2021, the subject experienced loss of voice, raspy voice, difficulty projecting voice. On 11-MAR-2021, the subject experienced sore throat. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from loss of voice, raspy voice, difficulty projecting voice, and the outcome of sore arm and sore throat was not reported. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment was not required as per standard procedure as the case assessed as non-serious
After receiving the vaccine, I started with chills and uncontrollable shaking. It followed by a headache, body aches, and extreme fatigue. I slept for 2 days. Within those 2 days I started to have a ringing in my right ear. The ringing is faint during the day, but it never stops. I also got covid and missed one week of work. I had a cough, fever, chills, and the same symptoms that I got from receiving the vaccine. These symptoms lasted for 5 days.
inappropriate age at vaccine administration; No adverse symptoms reported; This spontaneous report was received from a nurse concerning to a 2-month-old patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided.  On 10-APR-2020, the patient was accidentally vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (dose and route of administration not reported; lot number  S022912 has been verified to be a valid lot number for Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (therapy type rHA) (PROQUAD), expiration date not reported, but upon internal review established as 19-JAN-2021) due to human error for prophylaxis. No adverse symptoms were reported.
Numbness from toes up to  T7. Nerve ending tingling, Pressure and spinal pain.
persistent fever despite Tylenol, started a few hours after vaccination, "blood shot" eyes, admitted to hospital
Pt had a tonic clonic seizure lasting 1-2 minutes about 2 minutes after Tdap, meningococcal and PPD were administered/placed. 911 called.
Initial misuse case was received from a health care professional on 23 OCT 2013. Cases were received on 21 March 2014 at GPV. This case is linked to the case 2014SA41844 (cluster case). A patients whose demographic details, medical history and concomitant medications were not reported received a dose of FLUZONE ID on an unspecified date (route, site, dose and batch number not reported). It was reported that on an unspecified date patient received vaccine in inappropriate age. Laboratory investigation were not reported. No adverse event was reported. List of documents held by sender: none
patient fainted, then regained consciousness, sweaty palms, palms turned bright red then pale white
Immunizations given at 12:06 pm. Child slept until approximately 3:30 pm after feeding. Gave tylenol when had the immunizations and again when awoke crying. Poor po intake during this time and vomited. Fed better the next morning, still irritable for the next 2 days. Mother reported after the 2 month visit, baby took a nap then awoke screaming. He was not consolable for 3 hours. His leg seemed sore to touch. He ate less that day. Acetaminophen did not alter cry or inconsolably. He went to sleep and woke the next day and returned to improved eating. There were no concurrent illnesses. Mom did not call the office after the 2 month visit, but did bring this up just prior to the 4 month shots at the office. Six days
Intense pain in all joints the day after vaccine for 48 hours. Uncommon tumor development on left extremity 4 months after vaccine.
Not right away,  maybe a week after initial vaccine, I began  to experience excruciating pain in my jaw and upper left side around my molars.  In 2005, 06   i underwent oral surgery for two dental implants. After the vaccine not only was my jaw extremely sore but my gums have receded.  My teeth seem to be slowly coming out.  Now when I smile I appear to have fangs. my teeth never been in such state.  In addition to extreme toothache pain,  I have THE MOST PAINFUL headaches, triggered by the toothaches.  I fell certain that complaints are a direct result of the vaccine.  I have yet to see a dentist or doctor.
no adverse reaction reported  expired vaccine was administered to patient. Lot expired 7/12/2020 and vaccine was administered 8/13/2020.  Reported to Merck and was given a case number and asked to include in VAERS.
Arm swollen, itchy, warm 3 days after injections. Advised BENADRYL. Reassured local reaction call if change or worse.
Burning sensation in vaccine arm. Moves to different places of arm.  Every day since booster.   I got flu vaccine at same time in other arm.
This is a spontaneous report from a contactable Medical Assistant (who called on behalf of a physician) through a Pfizer Sales Representative. A female patient of unspecified age received PREVNAR 13 at single dose, on unknown date. Medical history and concomitant medications were not provided. On an unspecified date the patient experienced paralysis of hands, stroke and severe swelling in both arms. The patient went to emergency room because of the swelling (she went to ER twice because of it). The reporter did not know how recent was the stroke. At time of the report the swelling got progressed. The Medical Assistant believed that the events were due to the vaccine as the situation developed immediately after giving the shot and the patient had to go to the emergency room twice. Events final outcome at time of report was unknown.
she was violently throwing up; had severe diarrhea for about 3 days.; This is a spontaneous report from a contactable consumer (patient's parent). A 22-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on an unspecified date ("a few weeks ago on Friday") as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date ("by Sunday afternoon") the patient experienced violently throwing up and severe diarrhea for about 3 days. The patient was not herself for about 6 days before returning to normal. The outcomes of throwing up and diarrhea were recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
It is warm to touch; red spot/rash around the injection site; red spot/rash around the injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of INJECTION SITE WARMTH (It is warm to touch), INJECTION SITE ERYTHEMA (red spot/rash around the injection site) and INJECTION SITE RASH (red spot/rash around the injection site) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE WARMTH (It is warm to touch), INJECTION SITE ERYTHEMA (red spot/rash around the injection site) and INJECTION SITE RASH (red spot/rash around the injection site). At the time of the report, INJECTION SITE WARMTH (It is warm to touch), INJECTION SITE ERYTHEMA (red spot/rash around the injection site) and INJECTION SITE RASH (red spot/rash around the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported by the reporter.  Treatment medications for these events were not reported by the reporter.   This case was linked to MOD-2021-212754 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: TCR: AE outcome
Within 15 secs of 2nd vaccine developed a burning in throat and then a feeling of a lump in throat.
Pregnant patient received the both vaccinations; This spontaneous prospective pregnancy case was reported by a physician and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant patient received the both vaccinations) in a 32-year-old female patient (para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 014M20A) for COVID-19 vaccination.    Co-suspect product included non-company product PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication.    The patient's past medical history included No adverse event. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) and IRON for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient started PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] (unknown route) at an unspecified dose. The patient's last menstrual period was on 22-Sep-2020 and the estimated date of delivery was 26-Jun-2021. On 26-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant patient received the both vaccinations). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-second week of the pregnancy and PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] during pregnancy.  On 26-Feb-2021, EXPOSURE DURING PREGNANCY (Pregnant patient received the both vaccinations) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment details were reported.  Action taken with mRNA-1273 in response to the event was not applicable.
Vaccine reaction, initial encounter, pain left deltoid, no erythema, vaccine given 4 days ago, suspect she is having localized pain from injection, fairly thin arms, making it more pronounced, treat supportively, stable condition at time of discharge, pain described as achy, hurts when moves her arm, pt. having some memory issues and relies on husband most of the time, arthralgias and myalgia, [t discharged home, tylenol prn, follow up with Dr if not improving over next 2 weeks.
Had a head cold that started a week after vaccination- escalated into serious chest tightness and inability to breath, consistent cough + wheezing until July 5th. I went to urgent care twice, first time was told it was bronchitis, medication did nothing. July 5th went back to urgent care and was put on an oxygen tank to help me breathe, prescribed prednisone + an inhaler with albuterol. I still have to take the inhaler before exercise and in the morning.   I am a vegan runner + trainer, very healthy 25 year old, no genetic or personal history of any lung condition. My chest now has been tight since vaccination #2.